The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOptiBiotix Health Share News (OPTI)

Share Price Information for OptiBiotix Health (OPTI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.00
Bid: 17.50
Ask: 18.50
Change: 0.00 (0.00%)
Spread: 1.00 (5.714%)
Open: 18.00
High: 18.00
Low: 18.00
Prev. Close: 18.00
OPTI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

DIRECTOR DEALINGS: Tesco chair invests GBP100,000; Dechra exec sells

Fri, 16th Apr 2021 15:17

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Friday and not separately reported by Alliance News:

----------

Tesco PLC - Welwyn Garden City, England-based grocer - Chair John Allan buys 44,426 shares at GBP2.25, worth GBP100,000 on Wednesday. Non-Executive Director Steve Golsby buys 8,608 shares at GBP2.25, worth GBP19,393, on Thursday.

----------

Dechra Pharmaceuticals PLC - Cheshire-based veterinary products - Tony Griffin, managing director of Dechra Veterinary Products EU, sells 25,000 shares at GBP38.52, worth GBP962,950, on Friday. Dechra says Griffin's sale is to widen his investment portfolio for long-term financial planning purposes. He continues to hold 45,650 shares.

----------

OptiBiotix Health PLC - York, England-based developer of compounds to treat obesity, high cholesterol, diabetes and skincare - Non-Executive Director Stephen Hammond buys 25,000 shares at 51.8 pence, worth GBP12,950, on Thursday. The purchase is his only holding, having joined the board in February. Hammond is a UK member of Parliament.

----------

4D Pharma PLC - Leeds-based live biotherapeutic products - Chief Executive Officer Duncan Peyton and Chief Scientific Officer Alex Stevenson take part in company's USD25.0 million equity raise in March. Peyton and Stevenson each subscribe for 658,840 shares at GBP1.10, together worth GBP1.4 million. Peyton now has 9.5 million shares, a 5.3% stake, and Stevenson 9.4 million.

----------

Power Metal Resources PLC - metals exploration and development in Africa, US and Canada - Chief Executive Paul Johnson buys 500,000 shares at 2.39p each, GBP11,957 in total, on Thursday. Johnson had bought another 500,000 shares on Thursday that was already reported, for a GBP23,452 total investment. He now has 62.5 million shares, a 5.5% stake.

----------

Parsley Box Group PLC - Edinburgh-based ready-meal deliveries - Non-Executive Chair Chris van der Kuyl and wife Heather buy 26,165 shares at GBP1.86 to GBP2.03, worth about GBP50,000, on April 1 and April 12. Van der Kuyl now holds 2.3 million shares directly and 1.6 million indirectly via 4J Studios Ltd, for a 9.4% total stake. Parsley listed on AIM on March 31 at an initial public offering price of 200p.

----------

InnovaDerma PLC - London-based beauty, personal care and life science products firm - Non-Executive Director Mark Ward buys 171,242 shares at 40.7p, worth GBP69,695, on Thursday. Ward now has 2.3 million shares, a 13.5% stake. He also has agreed to subscribe to 1.4 million new shares as part of InnovaDerma's placing announced back in January. Finance Director Andrew Dunderdale buys 24,937 shares at 40.1p, also on Thursday.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
17 Feb 2020 09:09

OptiBiotix Health signs North American distribution agreement for LPLDL

(Sharecast News) - Life sciences business OptiBiotix Health has inked a distribution agreement with Advanced NutriSolutions/Select Ingredient for the exclusive sale of its patented probiotic strain LPLDL in the United States and Canada.

Read more
12 Feb 2020 10:40

OptiBiotix Health Inks Licencing Deal For Yoghurt With LPLDL Probiotic

OptiBiotix Health Inks Licencing Deal For Yoghurt With LPLDL Probiotic

Read more
12 Feb 2020 09:11

OptiBiotix strikes deal for proprietary probiotic yoghurt

(Sharecast News) - Life sciences business OptiBiotix Health announced on Wednesday that its wholly-owned subsidiary ProBiotix Health has signed a licencing agreement with Granja Pocha for the inclusion of its patented probiotic strain, 'LPLDL', into a functional yoghurt product in Uruguay.

Read more
31 Jan 2020 15:29

OptiBiotix, Agropur Launch SlimBiome Product In North America

OptiBiotix, Agropur Launch SlimBiome Product In North America

Read more
31 Jan 2020 08:57

OptiBiotix and partner Agropur launch 'SlimBiome' in North America

(Sharecast News) - Life sciences company OptiBiotix Health and its partner Agropur announced the launch of 'SlimBiome' in the North American market on Friday.

Read more
28 Jan 2020 13:02

OptiBiotix Health Expands SlimBiome And GoFigure Distribution Deals

OptiBiotix Health Expands SlimBiome And GoFigure Distribution Deals

Read more
27 Jan 2020 09:50

AlfaSigma To Launch New Supplement Containing OptiBiotix Probiotic

AlfaSigma To Launch New Supplement Containing OptiBiotix Probiotic

Read more
17 Jan 2020 10:32

OptiBiotix Health Aims For Profit In 2020; Explores Nasdaq Listing

OptiBiotix Health Aims For Profit In 2020; Explores Nasdaq Listing

Read more
17 Jan 2020 08:08

OptiBiotix eyes profitability in 2020, explores Nasdaq listing

(Sharecast News) - Life sciences business OptiBiotix Health provided revenue guidance for its recently wrapped up trading year on Friday and told investors it was now eyeing up a dual-listing on the New York Stock Exchange as it forecast profitability in 2020.

Read more
8 Jan 2020 15:56

OptiBiotix Health reports successful results from hypertension study

(Sharecast News) - Life sciences business OptiBiotix Health announced on Wednesday that its fully-owned subsidiary ProBiotix Health, in partnership with Nutrilinea, has completed a successful human study for a new food supplement formulation containing 'LPLDL', and showed that the product could reduce high blood pressure, or hypertension.

Read more
8 Jan 2020 10:42

OptiBiotix Health's LPLDL Product Reduces Hypertension In Study

OptiBiotix Health's LPLDL Product Reduces Hypertension In Study

Read more
7 Jan 2020 08:58

Holland & Barrett Launching Product Containing OptiBiotix's SlimBiome

Holland & Barrett Launching Product Containing OptiBiotix's SlimBiome

Read more
19 Dec 2019 12:25

OptiBiotix Inks New SlimBiome Distribution Deal In Germany

OptiBiotix Inks New SlimBiome Distribution Deal In Germany

Read more
17 Dec 2019 13:44

OptiBiotix Health launches two products with partners in India

(Sharecast News) - Life sciences company OptiBiotix Health announced the commercial launch of two products formulated with its 'SlimBiome' product in the Indian market on Tuesday, in partnership with Anthem BioPharma and Zeon Life Sciences.

Read more
17 Dec 2019 12:25

OptiBiotix Health Launches Two SlimBiome-Based Products In India

OptiBiotix Health Launches Two SlimBiome-Based Products In India

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.